The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment
Cara Therapeutics, a biopharmaceutical company, announced that it has licensed worldwide rights to commercialize KORSUVA injection for the treatment of chronic kidney disease-associated pruritus.
Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.
A key strategic objective of Russian drug manufacturers is to start production of their own substances. One of the most successful full-cycle sites operates in the Yaroslavl region. This new resear...
GC Pharma, a South Korean biopharmaceutical company, announced the establishment of Curevo Inc. The newly established Seattle-based company's goal is to support GC Pharma's vaccine development activities.
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bioasis Technologies announ...
In addition to development of medicinal products for treatment of various oncological diseases, other most common Russian developments include drugs for the treatment of infectious and inflammatory diseases, wounds, and burns.
The industrial cluster became the first in the region to have been included in the list of industrial clusters and specialized organizations of industrial clusters of the Ministry of Industry and Trade of Russia.
Emulate Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED.